Literature DB >> 1587614

Antigens of Brucella abortus S19 immunodominant for bovine lymphocytes as identified by one- and two-dimensional cellular immunoblotting.

B M Brooks-Worrell1, G A Splitter.   

Abstract

Cellular immune responses are influential for protection against intracellular bacteria such as brucellae. Therefore, identification of Brucella abortus antigens that activate primed bovine lymphocytes is fundamental for discerning the breadth of cellular response in bovine brucellosis. Potentially antigenic components of B. abortus S19 were isolated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by nitrocellulose blotting. Specific one-dimensional blot segments induced proliferation of peripheral blood lymphocytes from all 25 of the vaccinated cattle tested and were defined as immunodominant. Individual proteins that stimulated lymphocyte proliferation were further characterized by two-dimensional cellular immunoblotting by two different approaches. Individual one-dimensional stimulatory blot segments were eluted, concentrated, and then subjected to two-dimensional cellular immunoblotting. Alternatively, entire two-dimensional gels containing all of the B. abortus components were blotted and nitrocellulose sections containing individual proteins were assayed for lymphocyte activation. Thirty-eight Brucella proteins that induced lymphocyte proliferation were resolved by both procedures. Phenotypic analysis of the proliferating cell population demonstrated the presence of CD4+, CD8+, and immunoglobulin M+ lymphocytes. Two immunogenic proteins, 12 and 31 kDa, identified by two-dimensional cellular immunoblotting, were subjected to partial N-terminal amino acid analysis. The 12-kDa protein was within the area of greatest lymphocyte proliferation, while the 31-kDa protein was chosen for comparison with a 31-kDa protein previously reported by others. A search of the National Biomedical Research Foundation protein data bank showed that the sequences were not homologous with other known proteins. Identification of Brucella proteins immunogenic for bovine lymphocytes provides an important step in distinguishing the various proteins involved in pathogenicity and/or disease resistance.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587614      PMCID: PMC257181          DOI: 10.1128/iai.60.6.2459-2464.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Direct blotting with viable cells of protein mixtures separated by two-dimensional gel electrophoresis.

Authors:  H Gulle; B Schoel; S H Kaufmann
Journal:  J Immunol Methods       Date:  1990-10-19       Impact factor: 2.303

Review 2.  The role of cell-mediated immunity in bacterial infections.

Authors:  H Hahn; S H Kaufmann
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec

3.  Induction of lymphocyte responsiveness by the outer membrane-peptidoglycan complex of rough strains of Brucella abortus.

Authors:  R Smith; L G Adams; B A Sowa; T A Ficht
Journal:  Vet Immunol Immunopathol       Date:  1990-09       Impact factor: 2.046

4.  Determination of bovine lymphocyte responses to extracted proteins of Brucella abortus by using protein immunoblotting.

Authors:  B Brooks-Alder; G A Splitter
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

5.  Comparative immune responses to native cell envelope antigens and the hot sodium dodecyl sulfate insoluble fraction (PG) of Brucella abortus in cattle and mice.

Authors:  A J Winter; G E Rowe
Journal:  Vet Immunol Immunopathol       Date:  1988-03       Impact factor: 2.046

6.  The cloning, expression, and nucleotide sequence of a gene coding for an immunogenic Brucella abortus protein.

Authors:  J E Mayfield; B J Bricker; H Godfrey; R M Crosby; D J Knight; S M Halling; D Balinsky; L B Tabatabai
Journal:  Gene       Date:  1988       Impact factor: 3.688

7.  Effects of nonionic, ionic, and dipolar ionic detergents and EDTA on the Brucella cell envelope.

Authors:  I Moriyon; D T Berman
Journal:  J Bacteriol       Date:  1982-11       Impact factor: 3.490

Review 8.  Human brucellosis.

Authors:  E J Young
Journal:  Rev Infect Dis       Date:  1983 Sep-Oct

9.  Outer membrane proteins of Brucella abortus: isolation and characterization.

Authors:  D R Verstreate; M T Creasy; N T Caveney; C L Baldwin; M W Blab; A J Winter
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

10.  THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE.

Authors:  G B MACKANESS
Journal:  J Exp Med       Date:  1964-07-01       Impact factor: 14.307

View more
  16 in total

1.  Evaluation of DNA encoding acidic ribosomal protein P2 of Cryptosporidium parvum as a potential vaccine candidate for cryptosporidiosis.

Authors:  Alvaro Benitez; Jeffrey W Priest; Humphrey N Ehigiator; Nina McNair; Jan R Mead
Journal:  Vaccine       Date:  2011-10-01       Impact factor: 3.641

2.  Cloning of Brucella abortus gene and characterization of expressed 26-kilodalton periplasmic protein: potential use for diagnosis.

Authors:  O L Rossetti; A I Arese; M L Boschiroli; S L Cravero
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

3.  Characterization, occurrence, and molecular cloning of a 39-kilodalton Brucella abortus cytoplasmic protein immunodominant in cattle.

Authors:  P A Denoel; T K Vo; A Tibor; V E Weynants; J M Trunde; G Dubray; J N Limet; J J Letesson
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

4.  Protection against infection in mice vaccinated with a Brucella abortus mutant.

Authors:  M L Boschiroli; S L Cravero; A I Arese; E Campos; O L Rossetti
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

5.  Recombinant L7/L12 ribosomal protein and gamma-irradiated Brucella abortus induce a T-helper 1 subset response from murine CD4+ T cells.

Authors:  S C Oliveira; Y Zhu; G A Splitter
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

6.  Brucella ribosomal protein L7/L12 is a major component in the antigenicity of brucellin INRA for delayed-type hypersensitivity in brucella-sensitized guinea pigs.

Authors:  G Bachrach; M Banai; S Bardenstein; G Hoida; A Genizi; H Bercovier
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

7.  Protection of mice against Brucella abortus 544 challenge by vaccination with recombinant OMP28 adjuvanted with CpG oligonucleotides.

Authors:  Purushottam Kaushik; Dhirendra K Singh; S Vinoth Kumar; Ashok K Tiwari; Gunjan Shukla; Shanker Dayal; Pallav Chaudhuri
Journal:  Vet Res Commun       Date:  2009-12-16       Impact factor: 2.459

8.  Isolation of Brucella abortus ssb and uvrA genes from a genomic library by use of lymphocytes as probes.

Authors:  Y Zhu; S C Oliveira; G A Splitter
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

9.  Subcloning and expression of the Brucella abortus L7/L12 ribosomal gene and T-lymphocyte recognition of the recombinant protein.

Authors:  S C Oliveira; G A Splitter
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

10.  Characterization of an 18-kilodalton Brucella cytoplasmic protein which appears to be a serological marker of active infection of both human and bovine brucellosis.

Authors:  F A Goldbaum; J Leoni; J C Wallach; C A Fossati
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.